CLC Bio Japan and World Fusion, a Japanese informatics management company, said this week that they are creating a high-throughput sequence analysis service center in Japan using CLC Bio’s enterprise platform and World Fusion’s Life Science Knowledge Bank database system.
CLC said that World Fusion will also serve as its integration partner in Japan. Further details about the how the center will operate were not provided.
Formed in February 1996, World Fusion has developed bioinformatics tools to manage, analyze, and process genetic information for pharmaceutical researchers. The Bio Knowledge module of its Life Science Knowledge Bank lest users search for gene or protein mechanisms from a database that contains protein, gene, genetic disease, and organ annotations culled from more than 20 public databases.
Among other features, the tool searches for gene synonyms, analyzes ontology functions, disease, and compounds using gene lists, and searches for orthologous genes and proteins that are drug targets.
CLC Bio said that it expects the partnership with World Fusion to further its expansion into the Japanese sequence analysis market, which the company said is growing rapidly.
“I'm impressed by the momentum of the Japanese market," said Thomas Knudsen, CEO of CLC, in a statement. "In a short time span, Japan has expanded their position as the premier market in Asia and we have recently added new staff locally to keep up with the current demand.”